| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2.1 | 53.5 | 15.9 |
| Total income | 2.1 | 53.5 | 15.9 |
| Profit before exceptional items & tax | 0.2 | 1.4 | 0.7 |
| Profit before tax | 0.2 | 1.4 | 0.7 |
| Net profit | 0.2 | 1.0 | 0.5 |
| Operating margin | 9.5% | 2.6% | 4.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -60.00% |
|---|---|
| Net profit, quarter on quarter | -80.00% |
| Revenue, year on year | -86.80% |
BSE results filing, BSE: 543594. Figures extracted from the filing.
Dipna Pharmachem Ltd: key numbers
- Share price
- ₹4.04
- Market cap
- ₹10.62 Cr
- Revenue (annual)
- ₹129.1 Cr
- Net profit (annual)
- ₹2.63 Cr
- P/E (TTM)
- 4.0×Sector 47.4×
- Promoter holding
- 9.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dipna Pharmachem Ltd
All →Dipna Pharmachem Other Announcement
Dipna Pharmachem Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR, detailing the distribution of equity shares.
Dipna Pharmachem Management Change
Dipna Pharmachem appointed two new Independent Directors effective May 11, 2026. Board committees were also reconstituted to enhance governance.
Dipna Pharmachem Board Meeting Date
Dipna Pharmachem scheduled a board meeting for July 1, 2026. The board will review audited half-year and annual financial results.
Dipna Pharmachem Other Announcement
Dipna Pharmachem Limited filed its Annual Secretarial Compliance Report for FY2026. The report notes procedural non-compliances regarding the appointment of a qualified Company Secretary.
Dipna Pharmachem Annual General Meeting
Shareholders approved appointing M/s. Jay Pandya & Associates as Secretarial Auditor for FY 2025-26 via postal ballot. The resolution passed with a 99.77% majority.
Dipna Pharmachem Annual General Meeting
Dipna Pharmachem Limited has published newspaper advertisements confirming the dispatch of postal ballot notices and providing details for remote e-voting. The advertisements appeared in Financial Express (English and Gujarati) on April 24, 2026. This filing is in compliance with SEBI Listing Obligations and Disclosure Requirements Regulations.